The company on April 10 recieved a notification from Nasdaq’s listing qualities department saying the company isn’t in compliance with the $10 million minimum stockholders’ equity requirement for listing, according to a news release.
The company has to submit a plan to regain compliance which may include an application to transger its common stock listing to the Nasdaq capital market. Surgalign plans to file documents on or before May 25 to regain compliance.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
